Wholesalers worried Zuellig issues escalating to foreign drug companies.

"The current wholesaler's margin issues of Zuellig" may not only give adverse impacts limitedly to Zuellig but also to other foreign drug corporations who were not associated with Zuellig and the wholesale distribution margins had not cut down. Accordingly Zuellig's rate-cutting policy should be blocked, the wholesalers circle said.

The above interpretation in fact revealed very persuasive, ...